Six Considerations for MMS
Prioritizing the six considerations below when developing and distributing UNIMMAP MMS helps ensure women can experience improved health outcomes for themselves and their babies.
Follow the United Nations International Multiple Micronutrient Antenatal Preparation formulation, which was designed by a workshop of experts organized by the WHO and UNICEF and represents the highest quality formulation.
Meet internationally recognized quality standards, such as those set by the United States Pharmacopoeia, the European Pharmacopoeia, the International Pharmacopoeia, the British Pharmacopoeia, and the Japanese Pharmacopoeia.
Provide Halal-certification for use by Muslim women, making it a product that is accessible to millions of women on every continent.
Kirk Humanitarian’s UNIMMAP MMS is currently provided in 180-count bottles – the recommended supplementation for a healthy pregnancy. Additional bottle sizes are available for demonstration projects, pilots and implementation research efforts for countries considering switching from IFA to MMS.
Ensure a 30-month shelf-stable lifespan, which allows it to ultimately reach more pregnant women due to its continued potency and safety as it moves through the supply chain.
Produce supplementation that is both affordable and cost-effective. Working with our manufacturing partner, we have been able to produce UNIMMAP MMS for approximately $.0123 USD a dose or $2.22 USD per woman per pregnancy. While this cost may not be replicable for production in small quantities, it is a benchmark price that manufacturers should strive to reach.